All Stories

  1. Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations

    Article • Frontiers in Immunology, December 2025, Frontiers

    Clauvis Kunkeng Yengo

  2. Highly genetically diverse variants of hepatitis C virus still predominate in Cameroon but with low frequency of mutations associated to resistance of NS5B polymerase-targeted antivirals

    Article • JAC-Antimicrobial Resistance, July 2025, Oxford University Press (OUP)

    Clauvis Kunkeng Yengo

  3. KIR2DL1 gene is a surrogate marker of protection against infection-related hospitalization among HIV-1 unexposed versus exposed uninfected infants in Cameroon

    Article • BMC Immunology, August 2024, Springer Science + Business Media

    Clauvis Kunkeng Yengo

  4. HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and resistance to neutralizing antibodies

    Article • iScience, August 2024, Elsevier

    Clauvis Kunkeng Yengo

  5. Killer-Cell Immunoglobulin-Like Receptors (KIR) in HIV-Exposed Infants in Cameroon

    Article • Journal of Immunology Research, January 2021, Hindawi Publishing Corporation

    Clauvis Kunkeng Yengo

  6. Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon

    Article • Heliyon, October 2020, Elsevier

    Clauvis Kunkeng Yengo

  7. Killer Cell Immunoglobulin-Like Receptor Genotypes and Haplotypes Contribute to Susceptibility to Hepatitis B Virus and Hepatitis C Virus Infection in Cameroon

    Article • OMICS A Journal of Integrative Biology, February 2020, Mary Ann Liebert Inc

    carole stephanie sake, Clauvis Kunkeng Yengo